.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Queensland Health
UBS
Johnson and Johnson
Cipla
Novartis
Deloitte
US Department of Justice
Citi
Medtronic

Generated: November 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 080270

« Back to Dashboard
NDA 080270 describes ISONIAZID, which is a drug marketed by Watson Labs, Ivax Sub Teva Pharms, Thepharmanetwork Llc, Hikma Intl Pharms, Mikart, Duramed Pharms Barr, Whiteworth Town Plsn, Panray, Halsey, Purepac Pharm, Sun Pharm Inds, Cmp Pharma Inc, Barr, Mk Labs, Sandoz Inc, Nexgen Pharma Inc, Impax Labs, Perrigo, Phoenix Labs Ny, Sandoz, Pharmavite, and Lilly, and is included in thirty-four NDAs. It is available from twenty-six suppliers. Additional details are available on the ISONIAZID profile page.

The generic ingredient in ISONIAZID is isoniazid. There are five drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the isoniazid profile page.

Summary for 080270

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antimycobacterials
Formulation / Manufacturing:see details

Medical Subject Heading (MeSH) Categories for 080270

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength100MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Chinese Patent Office
McKesson
Federal Trade Commission
US Department of Justice
Queensland Health
Harvard Business School
US Army
Healthtrust
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot